Increased Bioavailability of TNF-α in African Americans During In Vitro Infection: Predisposing Evidence for Immune Imbalance

Placenta

Volumn 28, Issue 8-9, 2007, Pages 946-950

  Menon, R ^a,b   Thorsen, P ^b   Vogel, I ^b,c   Jacobsson, B ^d   Williams, S M ^e   Fortunato, S J ^a  

^a Perinatal Research Center   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cytokines; Disparity; Prematurity; Preterm labor; Race

Indexed keywords

LIPOPOLYSACCHARIDE; MEMBRANE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

AFRICAN AMERICAN; ARTICLE; BIOAVAILABILITY; CAUCASIAN; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE PREDISPOSITION; EXPLANT; FEMALE; FETUS MEMBRANE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION; NEGRO; PRIORITY JOURNAL; PROTEIN FUNCTION; RACE DIFFERENCE; TISSUE HOMOGENATE; METABOLISM;

AFRICAN AMERICANS; BIOLOGICAL AVAILABILITY; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447511717     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2007.03.007     Document Type: Article

References (26)

1. Buck P., and Thiesen K. Increased preterm births impact U.S. infant mortality. Lippincotts Case Manag 11 (2006) 228-230
2. Mathews T.J., Menacker F., and MacDorman M.F. Centers for Disease Control and Prevention, National Center for Health Statistics. Infant mortality statistics from the 2002 period: linked birth/infant death data set. Natl Vital Stat Rep 53 (2004) 1-29
3. Martin J.A., Hamilton B.E., Sutton P.D., Ventura S.J., Menacker F., and Munson M.L. Births: final data for 2002. Natl Vital Stat Rep 52 (2003) 1-113
4. Demissie K., Rhoads G.G., Ananth C.V., Alexander G.R., Kramer M.S., Kogan M.D., et al. Trends in preterm birth and neonatal mortality among blacks and whites in the United States from 1989 to 1997. Am J Epidemiol 154 (2001) 307-315
5. Hogan V.K., Njoroge T., Durant T.M., and Ferre C.D. Eliminating disparities in perinatal outcomes-lessons learned. Matern Child Health J 5 (2001) 135-140
6. Hoyert D.L., Mathews T.J., Menacker F., Strobino D.M., and Guyer B. Annual summary of vital statistics. Pediatrics 2006 117 (2004) 168-183
7. MacDorman M.H., Minino A.M., Strobino D.M., and Guyer B. Annual summary of vital statistics - 2001. Pediatrics 110 (2002) 1037-1052
8. Cockey C.D. Premature births hit record high. AWHONN. Lifelines 9 (2005) 365-370
9. Foster H.W., Wu L., Bracken M.B., Semenya K., Thomas J., and Thomas J. Intergenerational effects of high socioeconomic status on low birthweight and preterm birth in African Americans. J Natl Med Assoc 92 (2000) 213-221
10. Lu M.C., and Halfon N. Racial and ethnic disparities in birth outcomes: a life-course perspective. Matern Child Health J 7 (2003) 13-30
11. Goldenberg R.L., Hauth J.C., and Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 342 (2000) 1500-1507
12. Fiscella K. Race, genes and preterm delivery. J Natl Med Assoc 97 (2005) 1516-1526
13. Fiscella K. Ethnic disparities in preterm births. The role of urogenital infections. Public Health Rep 111 (1996) 104-113
14. Fortunato S.J., Lombardi S.J., and Menon R. Ethnic disparity in membrane response to infectious stimuli: a possible explanation for observed differences in the incidence of prematurity. Am J Obstet Gynecol 190 (2004) 1557-1563
15. Rosenberg N.A., Pritchard J.K., Weber J.L., Cann H.M., Kidd K.K., Zhivotovsky L.A., et al. Genetic structure of human populations. Science 298 (2002) 2381-2385
16. Menon R., Swan K.F., Lyden T.W., Rote N.S., and Fortunato S.J. Expression of inflammatory cytokines (IL-1β, IL-6) in amniochorion. Am J Obstet Gynecol 172 (1995) 493-500
17. Shen H.M., and Pervaiz S. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 20 (2006) 1589-1598
18. Clark J., Vagenas P., Panesar M., and Cope A.P. What does tumour necrosis factor excess do to the immune system long term?. Ann Rheum Dis 64 iv (2005) 70-76
19. Beutler B., and Cerami A. The biology of cachectin/TNF - α primary mediator of the host response. Annu Rev Immunol 7 (1989) 625-655
20. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11 (2001) 372-377
21. McFarlane S.M., Pashmi G., Connell M.C., Littlejohn A.F., Tucker S.J., Vandenabeele P., et al. Differential activation of nuclear factor-kappa B by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly. FEBS Lett 515 (2002) 119-126
22. Baker S.J., and Reddy E.P. Modulation of life and death by the TNF receptor superfamily. Oncogene 17 (1998) 3261-3270
23. Fortunato S.J., Menon R., and Lombardi S.J. Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol 187 (2002) 1159-1162
24. Menon R., Lombardi S.J., and Fortunato S.J. TNF-alpha promotes caspase activation and apoptosis in human fetal membranes. J Assist Reprod Genet 19 (2002) 201-204
25. Tracey K.J., Morgello S., Koplin B., Fahey III T.J., Fox J., Aledo A., et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J Clin Invest 86 (1990) 2014-2024
26. Menon R., Velez D.R., Thorsen P., Vogel I., Jacobsson B., Williams S.M., et al. Ethnic differences in key candidate genes for spontaneous preterm birth: TNF-alpha and its receptors. Hum Hered 62 (2006) 107-118 Epub 2006 Oct 17